Register an account to search through 14,000+ stocks! 

Ad

LON – Lonza Group AG

Ad

✔ COMPLIANT

★★★

Biotechnology & Medical Research | Europe

Business: PASS

Lonza Group AG has cleared the Business screen. Its business activity is compliant with the Shariah standard. If you find this result mistaken or questionable, let us know in the comments.

Financials: PASS

The financials pass all the three standards we check against.

FTSE

Debt/A14.6%
Cash/A9.61%
(AR+C)/A9.61%

AAOIFI

Debt/MC5.34%
Cash/MC3.56%

DJIM

Debt/24MC5.53%
Cash/24MC3.64%
AR/24MC%

Total Analysts: 22

Recommendation Rating

2.1

1

2

3

4

5

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 837.6

Low: 22

High: 1021.4

Market cap49329311623
Assets18043192282
Dividends per Share3.29
Revenue Growth17.2

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company’s offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company’s Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.

✔ FTSE✔ AAOIFI✔ DJIM

✔ COMPLIANT

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan.

Ad

Responses